NEOLEUKIN THERAPEUTICS INC's ticker is and the CUSIP is 64049K904. A total of 1 filers reported holding NEOLEUKIN THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $0 | – | 500 | 0.0% | 0.00% | – |
| Q3 2022 | $0 | -100.0% | 500 | -95.6% | 0.00% | – |
| Q2 2022 | $11,000 | -60.7% | 11,400 | -26.0% | 0.00% | – |
| Q1 2022 | $28,000 | -41.7% | 15,400 | +52.5% | 0.00% | – |
| Q4 2021 | $48,000 | +77.8% | 10,100 | +260.7% | 0.00% | – |
| Q3 2021 | $27,000 | +8.0% | 2,800 | 0.0% | 0.00% | – |
| Q2 2021 | $25,000 | +733.3% | 2,800 | +93233.3% | 0.00% | – |
| Q1 2021 | $3,000 | -85.7% | 3 | -80.0% | 0.00% | – |
| Q4 2020 | $21,000 | -73.1% | 15 | -68.1% | 0.00% | – |
| Q2 2020 | $78,000 | -12.4% | 47 | -40.5% | 0.00% | – |
| Q1 2020 | $89,000 | -65.2% | 79 | -62.0% | 0.00% | -100.0% |
| Q4 2019 | $256,000 | – | 208 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |